Procerus sign

Progressive Supranuclear Palsy (PSP) - Epidemiology Forecast - 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 9, 2020
Health, Other Health, Neurological disorders, Cognitive disorders, Rare diseases, Syndromes, Parkinson's disease, Progressive supranuclear palsy, Parkinsonism, Procerus sign

The "Progressive Supranuclear Palsy (PSP) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Progressive Supranuclear Palsy (PSP) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Progressive Supranuclear Palsy (PSP) is an adult onset, progressive, sporadic neurodegenerative disease and an important cause of atypical Parkinsonism.
  • The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Prevalence of Progressive supranuclear palsy, Phenotype associated with Progressive supranuclear palsy, Gender specific Prevalence of Progressive supranuclear palsy, Comorbidities associated with Progressive supranuclear palsy) scenario of Progressive supranuclear palsy in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2030.
  • The report covers detailed overview of Progressive supranuclear palsy explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
    The report provides the insight about the historical and forecasted patient pool of Progressive supranuclear palsy in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) and Japan
    The report provides the segmentation of the disease epidemiology by prevalence of Progressive supranuclear palsy, phenotype associated with Progressive supranuclear palsy, gender specific prevalence of Progressive supranuclear palsy, comorbidities associated with Progressive supranuclear palsy
    5 Disease Background and Overview: Progressive Supranuclear Palsy (PSP)

CurePSP Awards Seven New Research Grants

Retrieved on: 
Monday, July 29, 2019
Philanthropy, Health, Other Philanthropy, Foundation, General Health, Neurological disorders, Cognitive disorders, Rare diseases, Organ systems, Neurodegenerative disorders, Progressive supranuclear palsy, Syndromes, Corticobasal degeneration, Dementia, Corticobasal syndrome, Procerus sign

CurePSP, the foundation for prime of life neurodegeneration, has awarded grants to scientific research into progressive supranuclear palsy (PSP) and related diseases totaling more than USD 200,000.

Key Points: 
  • CurePSP, the foundation for prime of life neurodegeneration, has awarded grants to scientific research into progressive supranuclear palsy (PSP) and related diseases totaling more than USD 200,000.
  • The funding includes two Venture Grants totaling USD 190,000 and five student grants of USD 3,000 each.
  • CurePSP also awarded five student grants, funded by a bequest from the estate of Paul D. and Ruth T. Urso.
  • CurePSP is the nonprofit advocacy organization focused on progressive supranuclear palsy, corticobasal degeneration and other prime of life neurodegenerative diseases.